93 related articles for article (PubMed ID: 21611090)
1. Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.
Tada M; Nakai Y; Sasaki T; Hamada T; Nagano R; Mohri D; Miyabayashi K; Yamamoto K; Kogure H; Kawakubo K; Ito Y; Yamamoto N; Sasahira N; Hirano K; Ijichi H; Tateishi K; Isayama H; Omata M; Koike K
World J Clin Oncol; 2011 Mar; 2(3):158-63. PubMed ID: 21611090
[TBL] [Abstract][Full Text] [Related]
2. New developments in systemic therapy for advanced biliary tract cancer.
Morizane C; Ueno M; Ikeda M; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2018 Aug; 48(8):703-711. PubMed ID: 29893894
[TBL] [Abstract][Full Text] [Related]
3. Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer.
Park SJ; Kim H; Shin K; Lee MA; Hong TH
World J Gastrointest Oncol; 2019 Nov; 11(11):1021-1030. PubMed ID: 31798782
[TBL] [Abstract][Full Text] [Related]
4. Genomics and pharmacogenomics of pancreatic adenocarcinoma.
Lowery MA; O'Reilly EM
Pharmacogenomics J; 2012 Feb; 12(1):1-9. PubMed ID: 22186617
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of erlotinib in combination with gemcitabine in in vitro and in vivo models of KRAS-mutated pancreatic cancers.
Furugaki K; Iwai T; Kondoh K; Moriya Y; Mori K
Oncol Lett; 2010 Mar; 1(2):231-235. PubMed ID: 22966286
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer.
Lee J; Hong TH; Lee IS; You YK; Lee MA
Cancer Res Treat; 2015 Apr; 47(2):259-65. PubMed ID: 25648099
[TBL] [Abstract][Full Text] [Related]
7. Advanced biliary tract cancers.
Goff LW; Berlin JD
Am Soc Clin Oncol Educ Book; 2012; ():281-2. PubMed ID: 24451749
[TBL] [Abstract][Full Text] [Related]
8. Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients.
Kieler M; Unseld M; Bianconi D; Schindl M; Kornek GV; Scheithauer W; Prager GW
J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32121198
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy for biliary tract cancer.
Furuse J; Okusaka T
Cancers (Basel); 2011 May; 3(2):2243-54. PubMed ID: 24212807
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis.
Liu GF; Li GJ; Zhao H
J Cell Biochem; 2018 Jan; 119(1):511-523. PubMed ID: 28608558
[TBL] [Abstract][Full Text] [Related]
11. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
Adis International Ltd
Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
[TBL] [Abstract][Full Text] [Related]
12. The Hepatobiliary and Pancreatic Oncology (HBPO) Group of the Japan Clinical Oncology Group (JCOG): history and future direction.
Furuse J; Ishii H; Okusaka T
Jpn J Clin Oncol; 2013 Jan; 43(1):2-7. PubMed ID: 23100604
[TBL] [Abstract][Full Text] [Related]
13. Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study.
Kus T; Aktas G; Kalender ME; Sevinc A; Camci C
J Gastrointest Cancer; 2017 Jun; 48(2):170-175. PubMed ID: 27714651
[TBL] [Abstract][Full Text] [Related]
14. Advancements in the management of pancreatic cancer: 2013.
Saif MW
JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
Weigt J; Malfertheiner P
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):395-7. PubMed ID: 20678012
[TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of biliary tract cancers.
Uson Junior PLS; Bogenberger J; Borad MJ
Curr Opin Gastroenterol; 2020 Mar; 36(2):85-89. PubMed ID: 31972599
[TBL] [Abstract][Full Text] [Related]
17. Combinational therapy: new hope for pancreatic cancer?
Shi S; Yao W; Xu J; Long J; Liu C; Yu X
Cancer Lett; 2012 Apr; 317(2):127-35. PubMed ID: 22138436
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial.
Markussen A; Jensen LH; Diness LV; Larsen FO
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32698410
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of tumour location and first-line chemotherapy regimen in locally advanced pancreatic cancer.
Takeda T; Sasaki T; Mie T; Furukawa T; Yamada Y; Kasuga A; Matsuyama M; Ozaka M; Sasahira N
Jpn J Clin Oncol; 2021 Apr; 51(5):728-736. PubMed ID: 33611490
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant Chemotherapy after Surgery for Pancreatic Cancer].
Furuse J
Gan To Kagaku Ryoho; 2016 Feb; 43(2):160-4. PubMed ID: 27067680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
